World's first medical networking and resource portal

Articles
Medical Articles
Mar11
HIV vaccine development necessary for a durable end to AIDS / HIV
HIV vaccine development necessary for a durable end to AIDS / HIV

PROF.DRRAM ,HIV/AIDS,SEX DIS.,SEX WEAK.& ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033,DELHI –NCR,IND
HIV/ AIDS,CANCER LATEST MEDICINES AVAILABLE AT CHEAP RATE.
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
.
Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately effective HIV vaccine is needed to reach this goal more expeditiously and in a more sustainable way, according to a new commentary from Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and colleague Hilary D. Marston, M.D., M.P.H.

In the piece, the authors note that behavioral, cultural and legal factors have hindered HIV prevention and treatment efforts and explain why those factors necessitate the development of an HIV vaccine. Although attempts to develop a vaccine have so far proven disappointing, recent advances offer encouraging areas for HIV vaccine researchers to pursue, according to the authors. Notably, the discovery of naturally occurring broadly neutralizing antibodies against HIV and studies of their stimulation in infected individuals have opened new avenues in vaccine development. Using improved understanding of those antibodies and the specific sites on HIV to which they bind, the natural process of antibody evolution could be replicated and greatly expedited allowing protection against initial infection. Significant advances also have been made in understanding T-cell responses that may be important to vaccine-induced immunity against HIV.

The authors conclude that "the HIV prevention community should hold fast to its commitment to vaccine science. Ultimately, we believe, the only guarantee of a sustained end of the AIDS pandemic lies in a combination of nonvaccine prevention methods and the development and deployment of a safe and sufficiently effective HIV vaccine."


Category (Sexuality & Venereal Disorders)  |   Views (4736)  |  User Rating
Rate It


Feb23
HIV/AIDS:ZERO INFECTION OF HIV NEEDS UNIVERSAL VOLUNTARY SCREENING
HIV/AIDS:ZERO INFECTION OF HIV NEEDS UNIVERSAL VOLUNTARY SCREENING

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
Universal voluntary screening for young people and adults for HIV, a virus affecting the immune system which eventually causes AIDS, has been backed by high profile groups in the US, including the United States Preventative Services Task Force (USPSTF), an independent group of national experts who provide advice and recommendations to improve the health of Americans.
Previously we were using HIV /AIDS sreening for only hiv risk group like MSM,FSW,COMERICAL SEX WORKERS,PT SUFFERING FROM STDs,truck Drivers,Migratory Workers etc and it also included every Blood Transfusion and antenatal mother at Antenatal Clinic in country like India and abroad but as NOW THEME OF HIV INFECTION IS ZERO INFECTION THE WE HAVE TO SCREEN EVERY BODY AS TO DETECT THIS INFECTION AT EARLY STAGE AND TREAT HIM IMMEDIATELY SO THAT CONDITION NEVER WORSENS,MORE COUNSELLING OF THESE PATIENTS FOR FURTHER AWARENESS REGARDING HIV SO THAT OPPURTUNISTIC INFECTION NEVER HAPPENS.

The recommendation includes the desire that universal screening is done with correct notice of the impact a positive or negative result may have, while patients can ‘opt out’ of the process before being tested due to the sensitive nature of potential outcomes. This unusual opting out method as opposed to an opting in process of screening is very different from previously drawn out processes of counselling and testing, now seen as a barrier by many in the US towards a suitably modern screening approach towards a less stigmatised HIV illness.

Benefits of HIV screening
Public encouragement of widespread screening for HIV is now seen as a priority in order to identify those infected by the disease yet to experience symptoms, which may not appear for many years, therefore increasing risk of spreading the virus unknowingly. Because of recent advances in effective treatment of the condition, it’s becoming increasingly vital to capture the disease in its early stages, improving both long-term personal health and the safety of others.


Category (Sexuality & Venereal Disorders)  |   Views (8380)  |  User Rating
Rate It


Feb19
HIV /AIDS: IF CD4s Are High, A Multivitamin WITH SELENIUM Slows HIV even patient Without ARVs-raises cd4 count
HIV /AIDS: IF CD4s Are High, A Multivitamin WITH SELENIUM Slows HIV Without ARVs

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
.

A particular combination of multivitamins along with selenium slows HIV disease progression among those who are treatment naive and have a CD4 count above 350, aidsmap reports. Publishing their findings in the Journal of the American Medical Lab Technician Associasion
tion, researchers conducted a double-blind, placebo-controlled study of 878 treatment-naive people in Botswana between 2004 and 2009.

The median CD4 count among the participants was 420 at the beginning of the study; one in three of them had CD4s above 500. All were asymptomatic, had HIV-1 subtype C and had a normal body weight.

The participants were randomized to four groups to take different daily regimens over a 24-month period. One took a placebo. The second took daily multivitamins (B vitamins and vitamins C and E). The third took just selenium. And the last took the multivitamins and selenium.

Those who took just the multivitamins or who took them along with selenium were significantly less likely to have their CD4s drop below 250. Taking both the multivitamins and selenium lowered the risk of CD4s falling below 350.

There were no adverse side effects. Ninety percent of the participants adhered very well to the regimen, taking at least 96 percent of their doses.


Category (Sexuality & Venereal Disorders)  |   Views (8023)  |  User Rating
Rate It


Feb18
HIV /AIDS INFECTION :SOME COMMON FACTS OF THIS DREADLY INCURABLE DISEASE-READ & LEARN
HIV /AIDS INFECTION :SOME COMMON FACTS OF THIS DREADLY INCURABLE DISEASE

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
HIV is a complex disease that continues to take its toll around the world. For those living with the disease, understanding it is key to staying healthy. For those of us who aren't infected, an important key to staying that way is to understand how the disease spreads from person to person. This feature presents ten facts about HIV that everyone should know.
1. The Biology of HIV
Human Immunodeficiency Virus (HIV); the epidemic of the 20th Century. But what exactly is HIV and what does it do to our bodies? Understanding HIV could mean the difference between being infected or not infected; the difference between being healthy and being sick.
2. HIV Transmission - How Does it Happen?
In the beginning, people believed HIV was limited to one group of people: gay men. Obviously we now know that isn't true at all. We know that anyone can be infected with HIV if precautions are not taken. But in order to know which precautions to take, we must know how HIV is spread from person to person.
3. Who Can Get Infected with HIV?
The simple answer to this question is: anyone can get infected with HIV if they're exposed to it. People from all races, ethnicities, genders, and sexual orientations can get the virus. Young, old, teens, babies, married and single; in short, we are all at risk if we don't take the proper precautions. How do people get infected? Among other ways, babies born to HIV-infected women can, anyone who has sex with an infected person can, people who share needles with an infected person can, or someone who's received a transfusion from an un-screened blood supply can.
4. People are Still Dying from HIV and AIDS
In the developed countries of the world, great strides have been made, and as a result fewer people are dying of HIV-related illnesses. However, in some parts of the world; in countries where resources for education, prevention, and treatment are limited, people are still dying. These numbers show just how many.
5. People are Living - Thanks to HIV Medications
People are living near-normal life spans despite being infected with HIV. Over the years, medications have come and gone; being in and out of favor or replaced by newer, more effective and easier-to-take combinations. With these meds, people are living long, healthy lives. Take a look at the current list of HIV drugs available.
6. PEPFAR is Helping People Around the World Live with HIV
The President's Emergency Plan for AIDS Relief (PEPFAR) is what some believe to be President George W. Bush's most worthwhile accomplishment as President. The funding provided by PEPFAR has arguably saved millions of lives around the world. Let's get the lowdown on PEPFAR.OBAMA has further added to it free insurance for HIV DETECTION AND TREATMENT OF HIV AND ITS OPPURTUNISTIC INFECTIONS.
7. Breastfeeding and HIV Just Don't Mix
The benefits of breastfeeding are undisputed, but unfortunately women who are living with HIV should not breastfeed; the risk to their babies is just too high. For some women, though, there is no choice. Without clean water or resources for baby formula, breast feeding is the only option; a fact that has contributed to the HIV problem in places like Sub-Sahara Africa. Click through to read why breastfeeding with HIV is so risky.
8. Mother-to-Baby Transmission Can Be Avoided
HIV transmission from mother to unborn child is relatively common if steps aren't taken to decrease that risk. In fact, without proper prenatal and postnatal care of mother and baby, the infection rate is about 1 in 4. Luckily, there are steps that can be taken to reduce the risk of HIV transmission during pregnancy dramatically.
9. HIV and Tuberculosis - A Deadly Combination
Tuberculosis (TB) is a disease that is spread from person to person through the air, and it is particularly dangerous for people infected with HIV. Tuberculosis and HIV is a deadly combination. In fact, worldwide TB is the leading cause of death among people infected with HIV. Find out more about why TB is so deadly; especially when combined with HIV.
10. Great News - HIV Can Be Prevented!
The correct and consistent use of latex condoms during sexual intercourse- vaginal, anal, or oral-can greatly reduce a person's risk of acquiring or transmitting most STDs, including HIV, gonorrhea, chlamydia, trichomonas, human papilloma virus infection (HPV), and hepatitis B.


Category (Sexuality & Venereal Disorders)  |   Views (7644)  |  User Rating
Rate It


Feb16
HIV /AIDS VIRAL LOAD AND HIV TRANSMISSION RISK
HIV /AIDS VIRAL LOAD AND HIV TRANSMISSION RISK

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
HIV /AIDS IS CONTROLLED BY GOOD ARV OR ANTI RETROVIRAL MEDICINES AND AS WE START TTAKING MEDICINES REGULARLY WE FIND THAT OUR HIV QUANTITY IN OUR BODY IS DIMINISHED OR OUR VIRAL LOAD BECOMES LESS AND IT IS BELOW 50COPIES/ML OF BLOOD WE ASSUME THAT OUR VIRUS IN BODY IS VERY LESS AND NOW EVEN IF WE MEET OUR SEX PARTNER WITHOUT CONDOM RISK OF TRANSMISSION TO HIV NEGATIVE PARTNER IS MINIMAL BUT RISK BY BLOOD MIXING IS STILL IN GOOD PERCENTAGE.SO FOR HAVING CHILDREN SEX MAY BE ALLOWED ONCE OR TWICE WITHOUT CONDOM IN SERODISCORDANT (ONEPOSITIVE ANOTHER NEGATIVE) OR BOTH POSITIVES IF BOTH HAVE MINIMAL VIRAL LOAD BUT NOT MUCH SEX WITHOUT CONDOM ALLOWED AS IN BOTH POSITIVE TWO VARIETY OF HIV VIRUS OR GENOYPE MIX AND MAY CAUSE IT RESISTANT TO DRUG IN ONE PARTNER.
HOW MUCH TRUE IS ABOVE STATEMENT IS DEFINED BY STUDY DONE BELOW.
A January 2008 statement by the Swiss Federal AIDS Commission sparked considerable controversy, suggesting that HIV positive individuals on antiretroviral therapy who are fully adherent, maintain an undetectable viral load (below 40 copies/mL) for at least six months, and have no concurrent sexually transmitted infections are "not sexually infectious" (at least via heterosexual vaginal intercourse).

At the Mexico City conference, commission president Pietro Vernazza maintained that under the specific circumstances described, unprotected sex with a person with undetectable viral load carried a risk similar to that of sex using a condom: not 100% safe, but within a "comfortable range." But the risk is not non-existent, given that people on effective therapy may experience occasional transient viral load increases, or "blips," and that HIV may be present in genital and anal secretions even if it is undetectable in the blood.

As described in the July 26, 2008, issue of The Lancet, Australian researchers used a mathematical model to quantify the small transmission risk under the circumstances described in the Swiss statement. Assuming that each couple engaged in 100 sexual acts per year, they calculated the cumulative annual probability of transmission as .22% for female-to-male transmission, .43% for male-to-female transmission, and 4.3% for male-to-male transmission. In a population of 10,000 serodiscordant couples, this would translate to 215 expected instances of female-to-male transmission, 425 instance of male-to-female transmission, and 3,524 instances of male-to-male transmissionabout four times greater than the risk when using condoms.

"Although we agree that effective antiretroviral treatment which leads to undetectable viral load is likely to have a substantial effect on reducing infectiousness," the researchers concluded, "our analyses suggest that it should not replace condoms."


Category (Sexuality & Venereal Disorders)  |   Views (4787)  |  User Rating
Rate It


Feb15
HIV REMAINS CONCENTRATED AMONG GAY & FSW POPULATIONS AND IN CITIES
HIV REMAINS CONCENTRATED AMONG GAY & FSW POPULATIONS AND IN CITIES

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
.
The fastest-growing epidemics in the region OF ASIA ANDAFRICA AND EVEN IN HISPANIC AND SOUTH AERICA are among men who have sex with men; these epidemics are typically concentrated in major cities. Estimates based on country information IN FEW ASIAN COUNTRIES indicate that the regional population of men who have sex with men who are at risk of HIV infection ranges from 10.5–27 million. HIV prevalence among men who have sex with men is more than 10% in at least 10 major urban centres. 3 For example, the national prevalence for men who have sex with men in Thailand is estimated to be 7.1%; in Bangkok, levels are estimated to be 24.7%.
An estimated 3–4 million people living in Asia inject drugs. In three countries with expanding epidemics — Indonesia, Pakistan and the Philippines — injecting drug use has been a significant factor in the spread of HIV. In 2012, HIV prevalence among people who inject drugs was 36.4% in Indonesia, 27.2% in Pakistan and 13.6% in the Philippines. 5

National trends sometimes mask significant geographical variations in HIV prevalence among injecting drug users. In the Philippine province of Cebu, prevalence among people who inject drugs was estimated at 53.8% in 2011 compared with 13.6% nationally. 6 In the province of Thai Nguyen in Viet Nam, the prevalence among this group was reported to be 38.8% in 2012, compared with national prevalence of 11.6%. 7

There has been progress in reducing new HIV infections among female sex workers across the region. National prevalence has declined in the early epidemics of Cambodia, India, Myanmar and Thailand, and has been kept low in some countries including China, Nepal and the Philippines.

Nevertheless, challenges remain. Based on a global systematic review in low- and middle-income countries, the burden of HIV infection was disproportionately high among female sex workers, who are 13.5 times more likely to acquire HIV than the rest of the adult female population. The highest was observed among female sex workers in Asia and the Pacific, with a 29-fold increase in odds of living with HIV compared with all women of reproductive age. 8

As observed with other key populations, there are geographical areas with higher HIV prevalence — for example Hanoi, where prevalence among female sex workers was 22.5% in 2012 9 or Jayawijaya, Indonesia, 10 with 25% prevalence the same year. Even when national HIV prevalence trends among female sex workers have declined, for example in India and Myanmar, there are specific high-prevalence areas; 22% of female sex workers surveyed in Mumbai, India, and 15% surveyed in Pathein, Myanmar, were living with HIV. 11, 12

Data on male and transgender sex workers are scarce, but where available demonstrate high HIV prevalence. For example, 18% of surveyed male sex workers in Indonesia and Thailand tested HIV-positive, 13 as did 31% of transgender (waria) sex workers in Jakarta 14 and 19% in Maharashtra. 15 This underscores both the need for better data regarding male and transgender sex workers and for HIV programmes that address the needs of female, male and transgender sex workers.

Clients of sex workers are the largest population at risk of HIV infection in Asia and the Pacific. According to population-based surveys, 0.5% 16 –15% 17 of men in the region bought sex in the previous year. This population’s risk behaviour determines the extent of the spread of HIV, but there are limited data available on prevalence trends among clients of sex workers, and they are underserved by current HIV programmes. This emphasizes the need for more prevention efforts among key populations and reaching the female partners of men at higher risk both through key population programming and mainstreaming sexual and reproductive health services.

While evidence indicates that the majority of women in the region are acquiring HIV through their partners who engage in high-risk behaviour (including as sex work clients, through male-to-male sex or injecting drug use), policies and programmes to address intimate partner transmission are limited. Research conducted in Asia and the Pacific suggests that the transgender population in the region is around 9–9.5 million, made up predominantly of transgender women. 21 Little research has been done on their specific risk factors and data on HIV prevalence among transgender people is limited regionally, but global studies have found that transgender women are 50 times more likely to acquire HIV than adult males and females of reproductive age. The available data for the region indicate high HIV prevalence among transgender women in cities: 30.8% in Jakarta, 22 23.7% in Port Moresby 23 and 18.8% in Maharashtra, India (2010–2011 data).

More young people aged 15–24 live in Asia and the Pacific than in any other region. 25 In 2012, an estimated 690 000 young people were living with HIV (among which 46% are female). 26 The epidemic in this age group is driven mainly by unprotected sex and injecting drug use, as it is among adult populations. 27

Although there has been a 28% reduction of new HIV infections among children since 2001, recent rates of decline appear to be slowing. Between 2010 and 2012, infections among children decreased by 8%.


Category (Sexuality & Venereal Disorders)  |   Views (5852)  |  User Rating
Rate It


Feb12
HIV/AIDS.HEPAITIS B & HEPATITIS C RISK AFTER EXPOSURE TO INFECTED SOURCE ACCIDENTALLY :HOW TO PROTECT ONESELF AND MEASURES TAKEN TO CONTROL IT.
HIV/AIDS.HEPAITIS B & HEPATITIS C RISK AFTER EXPOSURE TO INFECTED SOURCE ACCIDENTALLY :HOW TO PROTECT ONESELF AND MEASURES TAKEN TO CONTROL IT.

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram

An exposure can be defined as a percutaneous injury (e.g., needlestick or cut with a sharp object) or contact of mucous membrane or nonintact skin (e.g., exposed skin that is chapped, abraded, or with dermatitis) with blood, saliva, tissue, or other body fluids that are potentially infectious Exposure incidents might place any time mostly of persons living contact (Family and social members),health personne treating them or accidentally other man coming in contact with different items used by infected persons as razor,blade,handerkerchief,bed,toilet sheet ,common water tub eating or drinking or using their clothes or meeting or talking or hugging or kissing them risk for hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV) infection.
In this regard it should be clear that hugging,using clothe using toilet sheet shaking hnds,eating or drinking with same glass or plate or using swimming tub or aircooler or room or bed or house or even kissing except very large oozing cut in mouth or skin and persons coming in direct contact with ozing but not old spatted blood of 30 minutes or more blood,semen,vaginal fluid,milk (not transmitting HCV),any body excertion except saliva,sweat or tear(very minimum)never transmit these diseases.TRANSMISSION BY AIR,WATER CONTACT WITH FOOD,CLOTHES,INSECT BITE,ANIMAL BITES NEVER OCCURS EVEN ANIMAL HIV ,HEPATITIS B OR C VIRUS DOESNOT AFFECT HUMAN AS IT IS SPECIES SPECIFIC BUT OTHER STDs may transmit.
Hepatitis B Virus (HBV):Health care workers who have received hepatitis B vaccine and have developed immunity to the virus are at virtually no risk for infection. For an unvaccinated person, the risk from a single needlestick or a cut exposure to HBV-infected blood ranges from 6%–30% and depends on the hepatitis B e antigen (HBeAg) status of the source individual. Individuals who are both hepatitis B surface antigen (HBsAg) positive and HBeAg positive have more virus in their blood and are more likely to transmit HBV.
Hepatitis C Virus (HCV);Based on limited studies, the estimated risk for infection after a needlestick or cut exposure to HCV-infected blood is approximately 1.8%. The risk following a blood splash is unknown but is believed to be very small; however, HCV infection from such an exposure has been reported.
Human Immunodeficiency Virus (HIV);The average risk for HIV infection after a needlestick or cut exposure to HlV-infected blood is 0.3% (about 1 in 300). Stated another way, 99.7% of needlestick/cut exposures to HIV-contaminated blood do not lead to infection.The risk after exposure of the eye, nose, or mouth to HIV-infected blood is estimated to be, on average, 0.1% (1 in 1,000).
The risk after exposure of the skin to HlV-infected blood is estimated to be less than 0.1%. A small amount of blood on intact skin probably poses no risk at all. There have been no documented cases of HIV transmission due to an exposure involving a small amount of blood on intact skin (a few drops of blood on skin for a short period of time). The risk may be higher if the skin is damaged (for example, by a recent cut), if the contact involves a large area of skin, or if the contact is prolonged.
What should be done following an occupational exposure?
Wounds and skin sites that have been in contact with blood or body fluids should be washed with soap and water; mucous membranes should be flushed with water. Immediate evaluation must be performed by a qualified health care professional.
There is no prophlactic medicine for hepatitis B for that precautions by wearing double gloves,washing hands fter touching patients or contacts wearing spectcles, dressing gown,Safe Blood,Safe protected sex with single condom male or female not double condoms and keeping utmost care while treating or being in touch with these patients is must.Donot avoid them tke only precautions simple precautions will protect .Hepatitis B vaccination is rule,for Hepatitis C no vaccination present take above precautions as stated above.Same is rule for HIV but beside if close contacts unavoidable as relatives new born or health personnel can take preprophylactic ARV AS TRUVADA or after exposure if Direct Blood contact as needle of blood in vein of treating health personnel or person highly infected with high viral load and blood coming out advise for three drug POST EXPOSURE PROPHYLAXIS DRUG FOR 28 DAYSif exposure less as blood of less infected person with breach over skin then TEO DRUG PROPHYLAXIS FOR 28 DAYS.
All used itmes by these persons particcularly Blood or body tissue must be burned or deep dug in side earth other as utensils,bed clothes should be washed properly using bleaching powder or phenyke if infected body secretions are spat over these otherwise simple washing is required.
INFECTED PERSON SHOULD NOT DONATE BLOOD OR THEIR ORGAN TO OTHER PERSONS EXCEPT NOW HIV DONATE ORGANS TO HIV PERSONS ONLY,SHOLD TKE PRECAUTIONS IF ANY RAW LEAKED SURFACE OR ULCER INSIDE MOUTH OR GENITILIA THEN FIRST GET IT TREATED BEFORE KISSING OR SEX WITH UNINFECTED PERSON.IF VIRAL LOAD LESS AND GOOD ARV TAKEN THEN CHANCE OF TRANSMISSION IS VERY LOW,SAME WITH HCV,HBV IF MEDICINE TAKEN THEN THESE ARE LESS INFECTIOUS.
IT IS PLEASURE THAT NO DISCRIMINATION OR STIGMA PAID TO THESE PERSONS, MIX WITH THEM ,LIVE WITH THEM SIMPLE PRECUTIONS BY BOTH SIDE PREVENT THESE DEADLY INFECTIONS.
Photo: HIV/AIDS.HEPAITIS B & HEPATITIS C RISK AFTER EXPOSURE TO INFECTED SOURCE ACCIDENTALLY :HOW TO PROTECT ONESELF AND MEASURES TAKEN TO CONTROL IT.

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram

An exposure can be defined as a percutaneous injury (e.g., needlestick or cut with a sharp object) or contact of mucous membrane or nonintact skin (e.g., exposed skin that is chapped, abraded, or with dermatitis) with blood, saliva, tissue, or other body fluids that are potentially infectious Exposure incidents might place any time mostly of persons living contact (Family and social members),health personne treating them or accidentally other man coming in contact with different items used by infected persons as razor,blade,handerkerchief,bed,toilet sheet ,common water tub eating or drinking or using their clothes or meeting or talking or hugging or kissing them risk for hepatitis B virus (HBV), hepatitis C virus (HCV), or human immunodeficiency virus (HIV) infection.
In this regard it should be clear that hugging,using clothe using toilet sheet shaking hnds,eating or drinking with same glass or plate or using swimming tub or aircooler or room or bed or house or even kissing except very large oozing cut in mouth or skin and persons coming in direct contact with ozing but not old spatted blood of 30 minutes or more blood,semen,vaginal fluid,milk (not transmitting HCV),any body excertion except saliva,sweat or tear(very minimum)never transmit these diseases.TRANSMISSION BY AIR,WATER CONTACT WITH FOOD,CLOTHES,INSECT BITE,ANIMAL BITES NEVER OCCURS EVEN ANIMAL HIV ,HEPATITIS B OR C VIRUS DOESNOT AFFECT HUMAN AS IT IS SPECIES SPECIFIC BUT OTHER STDs may transmit.
Hepatitis B Virus (HBV):Health care workers who have received hepatitis B vaccine and have developed immunity to the virus are at virtually no risk for infection. For an unvaccinated person, the risk from a single needlestick or a cut exposure to HBV-infected blood ranges from 6%–30% and depends on the hepatitis B e antigen (HBeAg) status of the source individual. Individuals who are both hepatitis B surface antigen (HBsAg) positive and HBeAg positive have more virus in their blood and are more likely to transmit HBV.
Hepatitis C Virus (HCV);Based on limited studies, the estimated risk for infection after a needlestick or cut exposure to HCV-infected blood is approximately 1.8%. The risk following a blood splash is unknown but is believed to be very small; however, HCV infection from such an exposure has been reported.
Human Immunodeficiency Virus (HIV);The average risk for HIV infection after a needlestick or cut exposure to HlV-infected blood is 0.3% (about 1 in 300). Stated another way, 99.7% of needlestick/cut exposures to HIV-contaminated blood do not lead to infection.The risk after exposure of the eye, nose, or mouth to HIV-infected blood is estimated to be, on average, 0.1% (1 in 1,000).
The risk after exposure of the skin to HlV-infected blood is estimated to be less than 0.1%. A small amount of blood on intact skin probably poses no risk at all. There have been no documented cases of HIV transmission due to an exposure involving a small amount of blood on intact skin (a few drops of blood on skin for a short period of time). The risk may be higher if the skin is damaged (for example, by a recent cut), if the contact involves a large area of skin, or if the contact is prolonged.
What should be done following an occupational exposure?
Wounds and skin sites that have been in contact with blood or body fluids should be washed with soap and water; mucous membranes should be flushed with water. Immediate evaluation must be performed by a qualified health care professional.
There is no prophlactic medicine for hepatitis B for that precautions by wearing double gloves,washing hands fter touching patients or contacts wearing spectcles, dressing gown,Safe Blood,Safe protected sex with single condom male or female not double condoms and keeping utmost care while treating or being in touch with these patients is must.Donot avoid them tke only precautions simple precautions will protect .Hepatitis B vaccination is rule,for Hepatitis C no vaccination present take above precautions as stated above.Same is rule for HIV but beside if close contacts unavoidable as relatives new born or health personnel can take preprophylactic ARV AS TRUVADA or after exposure if Direct Blood contact as needle of blood in vein of treating health personnel or person highly infected with high viral load and blood coming out advise for three drug POST EXPOSURE PROPHYLAXIS DRUG FOR 28 DAYSif exposure less as blood of less infected person with breach over skin then TEO DRUG PROPHYLAXIS FOR 28 DAYS.
All used itmes by these persons particcularly Blood or body tissue must be burned or deep dug in side earth other as utensils,bed clothes should be washed properly using bleaching powder or phenyke if infected body secretions are spat over these otherwise simple washing is required.
INFECTED PERSON SHOULD NOT DONATE BLOOD OR THEIR ORGAN TO OTHER PERSONS EXCEPT NOW HIV DONATE ORGANS TO HIV PERSONS ONLY,SHOLD TKE PRECAUTIONS IF ANY RAW LEAKED SURFACE OR ULCER INSIDE MOUTH OR GENITILIA THEN FIRST GET IT TREATED BEFORE KISSING OR SEX WITH UNINFECTED PERSON.IF VIRAL LOAD LESS AND GOOD ARV TAKEN THEN CHANCE OF TRANSMISSION IS VERY LOW,SAME WITH HCV,HBV IF MEDICINE TAKEN THEN THESE ARE LESS INFECTIOUS.
IT IS PLEASURE THAT NO DISCRIMINATION OR STIGMA PAID TO THESE PERSONS, MIX WITH THEM ,LIVE WITH THEM SIMPLE PRECUTIONS BY BOTH SIDE PREVENT THESE DEADLY INFECTIONS.


Category (Sexuality & Venereal Disorders)  |   Views (5747)  |  User Rating
Rate It


Feb03
HIV /AIDS LIFE EXPECTANCY : FACTORS GOVERNING LIFE OF AIDS PATIENTS
HIV /AIDS LIFE EXPECTANCY : FACTORS GOVERNING LIFE OF AIDS PATIENTS

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram

Factors that influence life expectancy are generally considered either static (or fixed) or dynamic (able to change or fluctuate over a short period of time).

Static factors, like race or sexual orientation, influence life expectancy not so much because a person is either white or African American,African,Indian or from any where or identifies as gay or heterosexual. Rather, longevity is associated with a multitude of risk factors within these specific population groups.

For instance, high levels of poverty in African American communities (24.9%),African indian poor patients and the consequential lack of access to healthcare negatively impacts the survival rate when compared to white population. Conversely, stigma reduction and access to community-specific HIV care may be contribute to the higher survival rates among men who have sex with men (MSM).

Dynamic factors, on the hand, generally have very strong causal effects insofar as survival time is concerned. Some of these, like treatment adherence, relate specifically to the preservation or deterioration of a person's immune function. Others, like smoking, contribute to the premature development of non-HIV-related comorbidities, such lung cancer. Still others, like injection drug use, are affected both fronts—both behavioral vulnerability and a person's vulnerability to infection.

CD4 count at the time of cART initiation remains one of the strongest indicators of life expectancy. Starting therapy at a CD4 count below 350 cells/ µL correlates to a quantitative reduction in life-years. Simply put, as the CD4 continues to dip beneath the 350 threshold, so, too, does life expectancy—by as much as 22 years, according to an analysis of the NA-ACCORD study data.

HIV-infected smokers lose more life-years to smoking than to HIV, say researchers from Department of Infectious Diseases at the University at Copenhagen. In fact, the risk of death from smoking is twice as high among smokers with HIV than those without. When compared to non-smoking people with HIV, smokers with HIV trim as much as 12 years from their lives, reducing life expectancy to just under 63 years.

Race and HIV longevity are integrally linked. Quite simply, HIV-positive non-whites live, on average, 8.5 year less than their white counterparts. That's a 15% difference, with the lowest life expectancy seen among African-Americans.

Injection drug users (IDUs) suffer from substantially increased mortality, both in terms of HIV-related infections and non-HIV-related comorbidities (like liver cancer). According to a collaborative cohort study of 6,269 IDUs in North America and Europe, the strongest contributing factors to lower life expectancy rates were treatment adherence and hepatitis C (HCV) co-infections. All told, life expectancy for IDUs is 20 (or more) years less than all other HIV groups.
Meanwhile, most research indicates that gender has no impact whatsoever on either disease progression or mortality. Moreover, white MSM are seen to have among the longest life expectancy of all HIV groups.
IN BRIEF IF TREATMENT STARTED SOON NOT BELOW 350 AS IN INDIA WITH GOOD ARV DRUGS HAVING LESS SIDE EFFECTS NOT AS IN INDIA ART CENTRES WHERE ONLY STAVUDINE NOT GIVEN BUT ZIDUVUDINE AND LAMOVUDINE AND NEVIRAPINE STILL USED EVEN PROTEASE INHIBITOR LIKE RALETAGIVIR, ATZANIVIR, INDIVINAVIR,LACKING MODERN INHIBITOR AND RECEPTOR BLOCKERS NOT USED BUT STILL REGUAR TREATMENT,GOOD ADHERANCE,A GOOD LIFE STYLE WITHOUT ADDICTION OF MULTIPLE SEX PARTNERS,DEVOID OF ALCOHOL,DRUGS AND CIGARETTE WITH GOOD DIET,NUTRITION AND TAKING PREVENTION FROM UNNECSSARY COLD HEAT,TRAUMA,PERSONAL FOOD AND WATER HYGEINE ALL LEADS TO GOOD SURVIVAL .PREVENTING IMMUNISATION WITH PREVENTIVE PROPHYLAXIS OF SOME INVECTION LIKE PNEUMONIA,DIARRHOEA,TOXOPLASMA ETC AND ERALY CHECK UP FOR OPPUTUNISTIC INFECTIONS ETC ALL LEADS TO GOOD SURVIVAL.
Drram Kumar's photo.
Drram Kumar's photo.
Drram Kumar's photo.
Drram Kumar's photo.
Like · · Share · Stop Notifications · Promote


Category (Sexuality & Venereal Disorders)  |   Views (2428)  |  User Rating
Rate It


Jan25
HIV /AIDS PATIENTS AND AGING :SCENARIO DIFFERENT IN UK /USA THAN INDIA-HOW TO CARE HIV AGED PERSONS
HIV /AIDS PATIENTS AND AGING :SCENARIO DIFFERENT IN UK /USA THAN INDIA

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
.

IN INDIA HIV /AIDS MOST PATIENTS ARE YOUNG AS few patients reach in old age above 50 as few continue medicines for very long but still many have cossed 55 by good life style and regular HIV medicines buy in USA By 2015, half of all New Yorkers living with HIV will be over 50 and in 2017, the same will be true of the entire United States.GMHC created social media campaigns directed at older people to address this need. Our “HIV is Ageless” campaign utilized images of men and women over 50 showing this demographic people who look just like them.We know HIV can infect a person at any age and that people over 50 have sex. We must be proactive in talking with our ‘eldersexuals’ about safer sex and the importance of getting tested.”

Medical research indicates that HIV accelerates the aging process. While we are still learning about the impact of anti-retroviral medications on the body, researchers have seen increased liver and kidney problems, higher incidences of cancer, depression, bone loss, frailty and some cognitive impediments among older people living with HIV and AIDS.

Beside awareness among these people for protected sex among themselves of same age or with younger partners use of condom is must beside prep medicine to partner.Following special care they need beside regular medicines with monitoring side effects of medicines or complication of disease.These care mostly provided in developed world but in our country too their good nutrition,psychosocial and working economical rehabilitation and mental support,providing regular medicines looking for BONE,FOOD INTAKE,RESPIRATORY DISEASES,LIVER,KIDNEY,SKIN AND CANCER IS MUST WHICH ARE MORE SEEN AS SIDE EFFECT OF DRUG OR COMPLICATION OF HIV ITSELG IN THIS OLD AGE
Nutrition Education:
GOOD NUTRITION AND EXCERCISE BOOSTUP IMMUNITY SO Certified and trained nutritionists provide counseling and enrollment in the food pantry program. Registered dieticians offer one-on-one counseling for clients who are interested in improving their health and quality of life through proper diet and nutrition.
Wellness Services:
Utilizing a holistic approach to client wellness, the Wellness center offers a variety of free, volunteer-led therapies and services, giving clients access to activities that may be otherwise unobtainable for those living with financial limitations, including yoga, massage therapy and exercise classes.

Mental Health Services:
GMHC provides individual, group and family counseling services to clients over fifty, which are always tailored to the client’s unique presentation of needs, and guided by treatment plans that are collaboratively developed. Common issues addressed by our mental health team involve adjustment to change, depression, anxiety, loss, grief, relationships, addictions and body image/esteem.
Advocacy and Benefits:
GMHC assists seniors daily in navigating their health care benefits and entitlement questions. An entire white paper about resources and needs of this population that is quickly becoming the majority of our HIV + population was written in preparation for this shift in population .

HIV Testing:
GMHC’s Geffen Center provides testing to people over the age of forty-five years, by providing point-of- care HIV rapid tests. Confirmatory tests are provided onsite on the same day preliminary positive results are given. Linkage to care is also initiated as soon as a preliminary positive result is given. Utilizing our Mobile Testing Unit, HIV Testing is offered at a number of NORC’s (Naturally Occurring Communities), and Testing is always available onsite at GMHC’s Center for HIV Prevention.

.


Category (Sexuality & Venereal Disorders)  |   Views (6881)  |  User Rating
Rate It


Jan25
HIV /AIDS CAN BE PREVENTED BY A PILL(TRUVADA)-HOW TRUE IS STATEMENT ?
HIV /AIDS CAN BE PREVENTED BY A PILL(TRUVADA)-HOW TRUE IS STATEMENT ?

PROF.DRRAM ,HIV/AIDS,SEX DISEASES,SEX WEAKNESS & ABORTION SPECIALIST
profdrram@gmail.com,+917838059592,+919832025033 DELHI –NCR,INDIA
FOLLOW ON FACE BOOK:www.facebook.com/drramkumar
FOLLOW ON TWITTER:www.twitter.com/profdrram
.
First time FDA in US approved a pill called Truvada (emtricitabine/tenofovir) as pre-exposure prophylaxis (PrEP) to prevent HIV in Negative persons like Sex partners of HOmosexuals and Heterosexals ,New born orchildrens or relatives and family members living in close contact with HIV positive very much exposed to HIV patients.
This is a good tool as now A PILL HAS BEEN USED AS PRE EXPOSURE PROPHYLAXSIS DRUG OR MEDICINE BT IT did not lead HIV-negative people in a large study to take increased sexual risks, although there are caveats to these findings,
Reuters reports. Approved in 2012 as an HIV prevention tool that can reduce the risk of transmission by more than 90 percent if used correctly, the antiretroviral has remained controversial,and sparsely used, in no small part because of concerns that it will lead to what is known as risk compensation. This phenomenon takes place when an individual responds to an intervention that lowers the risk of a harm by in turn exposing him or herself to greater risk of that harm—in this case, by having more unprotected sex or having sex with greater numbers of partners, for example. Such increased risk-taking could in theory negate the benefit of PrEP and also lead to the spread of other sexually transmitted infections (STIs).

Researchers at the Gladstone Institutes, an affiliate of the University of California, San Francisco, built upon their three-year 2010 Global iPrEx clinical study of Truvada as PrEP. Publishing their findings in PLOS ONE, they re-examined data of the nearly 2,500 HIV-negative gay men and male-to-female transgender women in six countries who participated, looking specifically at those who reported believing that they were not in the half of the study taking the placebo and also that the drug was working. Theoretically,those who believed to be on an effective HIV prophylaxis therapy would be more inclined toward risk compensation, but the investigators did not find this to be the case. In fact, the group’s behavior trended toward safer-sex practices. The rates of new HIV infections dropped four-fold. Syphilis rates fell as well.
Therefore,It has been concluded that this drug cannot be taken as CONVENTIONAL PILL USE IT AT A TIME OF SEX AND THROW AS CONDOM but has to be taken daily over months after a good medical checkup whether this drug or any other ARV MEDICINES can be used as prophylaxsis and its long term use need monitoring these persons clinically and by other investigations to ascertain whether any complication developing in them as we monitor HIV patients and with it more stress to protection by use of condom,Avoiding sex with multiple parteners,personal sexual Hygeine and protection from Blood or other secretions is a must if only PILLS TAKEN AND MULTIPLE SEX WITHOUT SAFE PRECATIONS IS DONE THEN IT MAY NOT RESLT IN BENEFIT AT ALL.
SO CONDOM AND GOOD LIVING STYLE IS BEST METHOD TP PREVENT HIV AND OTHER STDs this pill is very helpful but should be taken with above precautions too.


Category (Sexuality & Venereal Disorders)  |   Views (6509)  |  User Rating
Rate It


Browse Archive